1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components
(
- Contribution to journal › Article
- 2021
-
Mark
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
(
- Contribution to journal › Article
- 2020
-
Mark
Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion
(
- Contribution to journal › Article
-
Mark
Apolipoprotein A-I in glucose metabolism and amyloidosis
(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
(
- Contribution to journal › Article
- 2018
-
Mark
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism
(
- Contribution to journal › Article
- 2017
-
Mark
Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels
(
- Contribution to journal › Article
-
Mark
Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants
(
- Contribution to journal › Article
- 2016
-
Mark
Dual actions of apolipoprotein A-I on glucose-stimulated insulin secretion and insulin-independent peripheral tissue glucose uptake lead to increased heart and skeletal muscle glucose disposal
(
- Contribution to journal › Article